How a Leading Genomics Company Built a Full-Funnel Recruitment Pipeline with Curebase

Curebase eClinical Platform · Clinical Trial Technology Case Study

Finding the right patients for a clinical study is rarely simple. For a leading genomics company running a precision medicine study, the challenge was not just identifying eligible participants. It was reaching them quickly, qualifying them efficiently, and getting them enrolled before interest faded.

The Challenge

The study required a highly specific patient population, the kind that cannot simply be recruited through a generic ad campaign. The team needed a solution that could connect multiple partners, automate outreach at scale, and move patients through the funnel without friction.

The Setup

To solve for patient identification, the sponsor partnered with a national pharmacy chain with deep reach into the target demographic. The pharmacy identified patients in their network who met the study criteria and passed that list to the sponsor's team. From there, Curebase took over.

The Campaign

Using Curebase's campaign module, the team deployed a coordinated email and SMS outreach sequence to every patient on the list. The messaging was designed to be clear, approachable, and low-friction, meeting patients where they were and walking them through what participation would actually look like.

Interested patients were directed to a landing page and prescreening flow, where they could complete eligibility questions on their own time, from any device.

The Handoff

For patients who passed prescreening, including having a standard of care procedure scheduled already, Curebase's integration with a downstream enrollment partner meant that eligible participants were automatically routed for site follow-up and enrollment, with no manual intervention required. This meant instantaneous handoff and a clean data transfer without interrupting the participant's experience.

The Results

Every step of the process, from initial invite to site handoff, ran on its own. With Curebase handling the infrastructure, the teams were free to focus on what mattered most: getting the right patients into the study, as smoothly as possible.